ArticleMolecular biology reports2026
Co-existence of CLCN1 and DNM2 variants in a phenotype overlapping myotonia and myopathy.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMyotonia congenita (MC) is characterized by impaired muscle relaxation following contraction. Autosomal dominant centronuclear myopathy (ADCNM) is characterized by centrally located nuclei and muscle weakness. We aimed to identify potential pathogenic variants responsible for a phenotype overlapping severe myotonia and myopathy in an Iranian family.
methodsWe performed whole-exome sequencing on an index patient with clinical/electrical myotonia and myopathic changes on electromyography (EMG). We confirmed candidate genes by Sanger sequencing and performed co-segregation analyses.
resultsGenetic evaluation revealed two variants of NM_000083.3(CLCN1):c.1012 C > T (p.Arg338Ter) and NM_000083.3(CLCN1):c.1355 C > T (p.Pro452Leu) of the CLCN1 gene in a compound heterozygous state, consistent with recessive myotonia congenita. In addition, a heterozygous NM_001005361.3(DNM2):c.2161G > A (p.Asp721Asn) variant of uncertain significance (VUS) was identified in three affected brothers with myopathic features.
conclusionsThis study is a rare report of the co-existence of myotonia myopathy in an Iranian family. The findings support an autosomal recessive inheritance of myotonia congenita associated with the compound heterozygous CLCN1 variants. The co-occurring DNM2 p.Asp721Asn variant of uncertain significance (VUS) in affected individuals raises the possibility of its involvement in the accompanying myopathic phenotype; however, its contribution to the clinical manifestations remains uncertain and requires further investigation. These findings underscore the value of comprehensive genetic evaluation in patients with overlapping neuromuscular phenotypes.
Indexed as
Identifiers
42891863What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.